Assessing The Impact of Homoeopathic Medicines on Metabolic Syndrome Parameters: A Prospective Study
DOI:
https://doi.org/10.48165/ahr.2025.10.4.9Keywords:
Metabolic syndrome, complications, treatment, communicable diseasesAbstract
Background: Metabolic syndrome is a group of conditions that occurs together predisposing one to develop diabetes mellitus and cardiovascular complications. The major features of the Metabolic Syndrome are central obesity, hyperglycaemia, hypertriglyceridemia, low levels of high HDL-C and hypertension. Studies related to the efficacy of homoeopathy in Metabolic Syndrome are limited. Objective: To study the utility of homoeopathic medicines in Metabolic Syndrome Methods: A prospective clinical study was conducted at the outpatient department of Government Homeopathic Medical College, Kozhikode, using a one-group before-and-after design. The assessment was based on the change in total score before and after treatment, and the statistical test used was a paired t-test. Results: Among the subjects with Metabolic syndrome, both sexes showed equal preponderance. The highest prevalence of Metabolic syndrome was noted in the age group 50- 60 years. A majority of patients had a family history of diabetes mellitus and cardiovascular disease, indicating the possibility of hereditary influence. The study showed a significant difference in the total scores of assessment parameters before and after treatment of Metabolic syndrome with homoeopathic medicines. Additionally, more than 50% of subjects with metabolic syndrome had non alcoholic fatty liver disease (NAFLD), supporting the idea that NAFLD is the hepatic manifestation of Metabolic syndrome. Conclusion: Based on this study, homoeopathic medicines were found to be useful in managing Metabolic syndrome.
References
Saklayen, M. G. (2018). The global epidemic of the metabolic syndrome. Current Hypertension Reports, 20(2).
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome – A new worldwide definition. The Lancet, 366(9491), 1059–1062.
Leroith, D. (2002). β-Cell dysfunction and insulin resistance in type 2 diabetes. PDF.
Ghadge, A. A., & Khaire, A. A. (2019). Leptin as a predictive marker for metabolic syndrome. Cytokine, 121, 154735.
Mishra, S. K., et al. (2014). β-Cell dysfunction is associated with metabolic syndrome severity in adults. Metabolic Syndrome and Related Disorders, 12(2), 79–85.
Ramos, J. S., et al. (2017). Cardiorespiratory fitness is positively associated with increased pancreatic beta cell function independent of fatness. Journal of Science and Medicine in Sport, 20(1), 45–49.
Weir, G. C., et al. (2001). β-Cell adaptation and decompensation during the progression of diabetes. Diabetes, 50(Suppl. 1).
Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes, 37(12), 1595–1607.
Kaplan, M. (1989). The deadly quartet: Upper-body obesity, glucose intolerance. Archives of Internal Medicine, 149(7), 1514–1520.
Research, N. K-H. (1996). The deadly quartet and the insulin resistance syndrome: An historical overview. J-Stage.
Lemieux, I., & Després, J. P. (2020). Metabolic syndrome: Past, present and future. Nutrients, 12(11), 3501.
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005). The metabolic syndrome. The Lancet, 365(9468), 1415–1428.
Sarafidis, P. A. (2006). The metabolic syndrome: A glance at its history. Journal of Hypertension.
Magliano, D., Shaw, J., & Zimmet, P. Z. (2009). How to best define the metabolic syndrome. Taylor & Francis, 38(1), 34–41.
World Health Organization. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications (pp. 1–66).
Aguilar-Salinas, C. A., & Viveros-Ruiz, T. (2019). Recent advances in managing the metabolic syndrome. F1000Research.
Zafar, U., et al. (2018). Metabolic syndrome: An update on diagnostic criteria, pathogenesis, and genetic links. Hormones, 17(3), 299–313.
Grundy, S. M., et al. (2004). Definition of metabolic syndrome. Circulation, 109(3), 433–438.
Alberti, K. G. M. M., et al. (2009). Harmonizing the metabolic syndrome. Circulation, 120(16), 1640–1645.
Jameson, A., et al. (2015). Harrison’s principles of internal medicine (19th ed., pp. 2449–2454). McGraw-Hill Education.
Ralston, S., et al. (2018). Davidson’s principles and practice of medicine (23rd ed., pp. 882–885). Elsevier.
Reddy, P., et al. (2019). Metabolic syndrome as an inflammatory disorder. Clinica Chimica Acta, 496, 35–44.
Von Frankenberg, A. D., et al. (2017). Adiponectin levels and metabolic syndrome. Archives of Endocrinology and Metabolism, 61(6), 614–622.
Shetty, A., et al. (2018). Role of the circadian clock in metabolic syndrome. Digestive Diseases and Sciences, 63(12), 3187–3206.
Francisqueti, F. V., et al. (2017). Oxidative stress in metabolic syndrome. Revista da Associação Médica Brasileira, 63(1), 85–91.
Isomaa, B., et al. (2001). Metabolic syndrome and chronic complications in type 2 diabetes. Diabetologia, 44(9), 1148–1154.
Wang, H. H., et al. (2020). Pathogenesis and management of metabolic syndrome. Pediatric Gastroenterology, Hepatology & Nutrition, 23(3), 189.
Tenenbaum, A., et al. (2004). Macrovascular complications of metabolic syndrome. International Journal of Cardiology, 97(2), 167–172.
Nithin, R. M. (2019). A study on constitutional medicine in metabolic syndrome. Thesis.
Hideya, M., et al. (2018). St. John’s Wort in metabolic syndrome. OBM Integrative and Complementary Medicine, 3(3).
Martins, M. B., et al. (2019). Homeopathic adiponectin in mice. Revista de Homeopatia, 82(1/2), 1–12.
Ponnam, H. B., et al. (2021). Hypertriglyceridemia treated with Fucus vesiculosus. Journal of Ayurveda and Integrative Medicine, 12(3), 549–552.
S. K. (2016). Homeopathic medicine Rauwolfia serpentina in hypertension. Journal of Drug Research and Development, 2(1).
Mehra, P. (2015). Homeopathy in essential hypertension. International Journal of High Dilution Research, 14(1), 16–19.
Sandhu, R. C. C. (2018). Cure of obesity in homeopathy. Tantia University Journal of Homeopathic Medical Science, 1(1), 17–22.
Chakraborty, D. P. K. (2018). Homeopathic approach in diabetic patients. Tantia University Journal of Homoeopath Medical Science, 1(1), 6–8.
Eslam, M., et al. (2020). MAFLD definition. Journal of Hepatology, 73(1), 202–209.
Sanyal, A. J. (2019). NAFLD perspectives. Nature Reviews Gastroenterology & Hepatology, 16(6), 377–386.
Chalasani, N., et al. (2018). NAFLD diagnosis and management. Hepatology, 67(1), 328–357.
Sayyad, R. Z. K. (2017). NAFLD and homoeopathic treatment. International Journal of Research in AYUSH & Pharmaceutical Sciences, 1(6), 184–192.
Hahnemann, S. (2009). Organon of Medicine (5th & 6th ed.). B. Jain Publishers.
Hahnemann, S. (1999). The Chronic Diseases. B. Jain Publishers.
WHO Europe. Body mass index (BMI).
Misra, A., et al. (2006). Waist circumference cutoffs for Asian Indians. International Journal of Obesity, 30(1), 106–111.
World Health Organization. (2008). Waist circumference and waist–hip ratio. WHO Expert Consultation Report.
American Diabetes Association. (2019). Standards of medical care in diabetes. Diabetes Care, 42(Suppl. 1), S13–S28.
National Cholesterol Education Program. (2000). Understanding cholesterol levels. Postgraduate Medicine, 108(7), 125–126.
Olin, B. R. (2018). Hypertension: The silent killer – Updated JNC-8 guideline recommendations 2018.
